Related Experiment Video
Updated: Jun 21, 2025

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Diabetic Heart Disease: An Intricate Interplay of a Widespread Metabolic Disorder with the Cardiovascular System
A S Kamakshi Shriya1, Vaishnavi B Pawar1, Acsah Annie Paul1
1Department of Pharmacy Practice, JSS College of Pharmacy, JSS Academy of Higher Education and Research (JSSAHER), Mysuru, 570015, Karnataka, India.
Insights
Diabetes affects millions globally, increasing heart disease risk. This review examines hypoglycaemic drugs, differentiating between cardiotoxic and cardioprotective agents for diabetes management.
Area of Science:
- Endocrinology
- Cardiology
- Pharmacology
Background:
- Diabetes mellitus is a global epidemic, impacting over 422 million people, predominantly in low- and middle-income countries.
- High blood glucose levels in diabetes lead to long-term damage in vital organs, contributing to 1.5 million annual deaths.
- Diabetic patients face an elevated risk of cardiovascular conditions, including diabetic cardiomyopathy, coronary artery disease, and heart failure.
Purpose of the Study:
- To review current data on diabetic heart disease.
- To analyze the effects of various hypoglycaemic agents on cardiac health in diabetic patients.
Main Methods:
- Literature review of existing data on diabetes, heart disease, and hypoglycaemic agents.
- Analysis of studies investigating the cardiovascular effects of different classes of hypoglycaemic medications.
Main Results:
- Some hypoglycaemic agents, while managing blood glucose, exhibit cardiotoxicity.
- Other hypoglycaemic drugs offer cardioprotective benefits beyond glycaemic control.
- The incidence of diabetic heart disease is increasing worldwide.
Conclusions:
- Understanding the dual effects of hypoglycaemic agents is crucial for managing diabetic cardiovascular complications.
- Further research into cardioprotective hypoglycaemic therapies is warranted to mitigate mortality and morbidity in diabetic populations.
Abstract:
Diabetes is a chronic medical condition that causes high glycaemic levels, leading to damage to vital organs over time. It is a common disease worldwide, affecting around 422 million individuals living in middle- and low-income countries, which make up most of the population. Unfortunately, diabetes results in 1.5 million deaths annually. Diabetic patients are at a higher risk for developing cardiovascular conditions. Diabetic heart disease constitutes multiple genres, including diabetic cardiomyopathy, coronary artery disease, and heart failure. Hypoglycaemic agents aim to prevent these metabolic issues however some of these are cardiotoxic in nature. In contrast, other hypoglycaemic agents work beyond controlling glycaemic levels with their cardioprotective properties. Given that there is an alarming increase in diabetic heart disease cases universally, we have attempted to review the existing data on the topic and the effects of hypoglycaemic drugs on heart diseases.
More Related Videos
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
05:06Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Heart Failure Drugs: Diuretics